Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 77,63 € (+19,89%). La mediana è 74,21 € (+14,61%).
| Acquista |
13 |
| Mantieni |
10 |
| Vendi |
0 |
Discussioni nella community
Non ci sono ancora discussioni su questo asset.
Avvia discussioneNotizie Vai al feed delle notizie
Stifel Financial hits 52-week low at $67.95 despite strong quarterly results
Stifel Financial’s stock fell to a 52-week low of $67.95 and is currently trading near $67.89, giving it a market capitalization of about $10.45 billion. The shares have lost roughly 17.8% over six months and 16.2% year-to-date. At the same time, the company reported strong Q1 results with operating earnings per share of $1.45, revenue up 18% to $1.48 billion, assets under management of $579.7 billion and a dividend of $0.34 per share; analysts see valuation metrics suggesting undervaluation. » Altro su de.investing.com
Stifel Financial announces quarterly dividend of $0.34
Stifel Financial declared a cash dividend of $0.34 per common share, payable on June 15, 2026 to shareholders of record on June 1, 2026. The board also confirmed quarterly dividends for three series of preferred stock (Series B, C and D) with respective distributions of approximately $0.390625, $0.3828125 and $0.28125 per depositary share. The dividend reflects the company’s nine years of rising payouts; the current yield is 1.73 percent. Investor note: the preferred dividends cover the period from March 16 to June 15, 2026. » Altro su de.investing.com
Stifel exceeds Q1 2026 expectations on earnings and revenue, stock slightly under pressure
Stifel reports adjusted EPS of $1.45 for Q1 2026 (expectation $1.37) and revenue of $1.48bn (expectation $1.44bn), driven by strong investment banking fees. Despite the positive results, the stock fell 0.38% in pre-market trading to $81.96. Management highlights company-wide AI initiatives and venture lending as growth drivers and reaffirms a positive outlook with EPS guidance between $1.46 and $2.09 and expected Q2 revenue of about $1.47bn. Risks remain from market volatility, geopolitical tensions and interest-rate uncertainty. » Altro su de.investing.com
Acumen Pharmaceuticals presents Sabirnetug strategy at Stifel forum
Acumen Pharmaceuticals provided a strategic overview of Sabirnetug, which targets toxic, soluble Aβ oligomers in Alzheimer’s. The phase 2 ALTITUDE‑AD study with 542 recruits was completed in 10 months; results are expected at the end of 2026 and are seen as key to validating the Aβ oligomer hypothesis. The company is collaborating with JCR Pharmaceuticals to improve brain uptake using IZCARGO and aims to file an IND for the EBD program by mid‑2027. Acumen remains open to partnerships for phase 3 development, depending on the ALTITUDE‑AD results; the subcutaneous formulation will continue to be evaluated. » Altro su de.investing.com
Stifel Financial beats Q4-2025 forecasts, announces stock split and dividend increase
Stifel Financial reported Q4 2025 earnings per share of $2.63 (expectation $2.51) and revenue of $1.56 billion (expectation $1.5 billion). Management announced a 3-for-2 stock split and an 11% dividend increase. For 2026, net revenue is expected between $6.0 billion and $6.35 billion; 2025 was a record year with $5.5 billion. Despite the positive results, the stock moved little in premarket trading, and the company continues to show strong margins and a high return on tangible equity. » Altro su de.investing.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | settembre 2026 | YoY |
|---|---|---|
| Ricavi | 1,44 Mld | 4,66% |
| Utile lordo | 1,25 Mld | 4,15% |
| Utile netto | 206,71 Mln | 14,77% |
| EBITDA | 280,37 Mln | 7,11% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 9,65 Mld € |
Numero di azioni | 149,24 Mln |
Massimo/minimo a 52 settimane | 81,80 € - 59,55 € |
Rendimento da dividendo | 1,93% |
Dividendi TTM | 1,27 € |
Prossimo dividendo | 0,31 € |
Beta | 1,02 |
Rapporto P/E | 10,25 |
Rapporto PEG | 0,70 |
Rapporto P/B | 1,78 |
Rapporto P/S | 1,58 |
Profilo aziendale
Stifel Financial Corp., una società di partecipazione bancaria e di servizi finanziari, offre servizi di gestione patrimoniale e di banca d'investimento per privati e istituzionali a investitori individuali, società, enti locali e istituzioni negli Stati Uniti, nel Regno Unito, nel resto d'Europa e in Canada. L'azienda opera in tre segmenti: Global Wealth Management, Institutional Group e Altro. La società fornisce servizi per clienti privati, tra cui servizi di negoziazione di titoli e di pianificazione finanziaria; vendita, negoziazione e ricerca istituzionale su azioni e titoli di debito, nonché servizi di finanza municipale; servizi di banca d'investimento, come fusioni e acquisizioni, offerte pubbliche e collocamenti privati; e servizi bancari al dettaglio e commerciali, che comprendono programmi di prestiti personali e commerciali, oltre a conti di deposito. Partecipa inoltre alla gestione di sottoscrizioni per la finanza societaria e pubblica e offre servizi di consulenza finanziaria e di intermediazione mobiliare. La società è stata fondata nel 1890 e ha sede a St. Louis, Missouri.
| Nome | Stifel Financial Co. |
| CEO | Ronald James Kruszewski |
| Sede centrale | Saint Louis,
mo Stati Uniti |
| Sito web | |
| Settore | Finanza |
| Industria | Servizi finanziari |
| Quotazione in borsa | 19/07/1983 |
| Dipendenti | 8900 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NYSE | SF |
Frankfurt | 2SI.F |
Düsseldorf | 2SI.DU |